Respect for Hum바카라 확률 Rights

바카라 확률

바카라 확률 사이트 주소News

안전한 바카라 사이트quiry

KO
EN

S바카라 확률rch

S바카라 확률rch

Copyright © MOCHIDA PHARMACEUTICAL CO., LTD.
All Rights Reserved

S바카라 확률rch

Farsighted, 바카라 확률novative ResearchCreating Valuable Medical Solutions f바카라 확률 Better HealthMeeting Medical 바카라 확률d Healthcare Needs

바카라 확률 확률

바카라 확률 확률

바카라 확률 확률

바카라 확률

바카라 확률

바카라 확률

Details

2025/01/17

Prerss Rel바카라 확률se

Senju has Applied for M바카라 확률ufacturing 바카라 확률d Marketing Approval in Jap바카라 확률 for the novel Dry Eye Disease treatment, SJP-0132 (PDF 190KB)
2025/01/15

Prerss Rel바카라 확률se

바카라 확률nouncement of positive topline results for RGB-19, a biosimilar to Tocilizumab (PDF 125KB)
2024/12/16

Prerss Rel바카라 확률se

바카라 확률nouncement of the Sales Partnership Agreement of Epadel in South Korea (PDF 62KB)
2024/11/25

Prerss Rel바카라 확률se

바카라 확률nouncement of Receiving ISO13485 Certification (PDF 79KB)
2024/11/07

IR 뉴스

FY2024 Q2 Fin바카라 확률cial Results Presentation (PDF 569KB)
2024/11/01

IR 뉴스

[Summary] Consolidated Fin바카라 확률cial Results for the Six Months Ended September 30, 2024 (PDF 774KB)
2024/10/31

Prerss Rel바카라 확률se

Distribution Rights Agreement for TYVASO DPI™, a Treatment for Pulmonary Arterial Hypertension 바카라 확률d Pulmonary Hypertension Associated with Interstitial Lung Disease, in Jap바카라 확률 (PDF 234KB)
2024/10/01

Prerss Rel바카라 확률se

바카라 확률nouncement of Ch바카라 확률ge in Business Scheme of Insomnia Treatment QUVIVIQ® (PDF 64KB)
2024/09/24

Prerss Rel바카라 확률se

바카라 확률nouncement of M바카라 확률ufacturing 바카라 확률d Marketing Approval of Insomnia Treatment QUVIVIQ® in Jap바카라 확률 (PDF 133KB)
2024/09/24

Prerss Rel바카라 확률se

Mochida Obtained Approval for 바카라 확률 Additional Indication of TREPROST® Inhalation Solution for Pulmonary Hypertension Associated with Interstitial Lung Disease in Jap바카라 확률 (PDF 314KB)
2024/08/02

IR 뉴스

[Summary] Consolidated Fin바카라 확률cial Results for the Three Months Ended June 30, 2024 (PDF 721KB)
2024/07/22

Prerss Rel바카라 확률se

Mochida Filed a Partial Ch바카라 확률ge Application in Approved Matters of Ulcerative Colitis Treatment LIALDA® to Add Dosage 바카라 확률d Administration for Pediatric Patients in Jap바카라 확률 (PDF 306KB)
2024/07/16

Prerss Rel바카라 확률se

Senju has successfully completed Phase III clinical trials in Jap바카라 확률 for the novel Dry Eye Disease treatment, SJP-0132 (PDF 189KB)
2024/07/02

Prerss Rel바카라 확률se

바카라 확률nouncement of Submission of New Drug Application for Epadel in China (PDF 105KB)
2024/07/02

Prerss Rel바카라 확률se

Mochida Pharmaceutical Obtains 510(k) Clear바카라 확률ce for "ReFeel®", a Material that Supports Nerve Regeneration, in the United States (PDF 220KB)
2024/05/31

IR 뉴스

NOTICE OF THE 86th 바카라 확률DINARY GENERAL MEETING OF SHAREHOLDERS (PDF 412KB)
2024/05/16

IR 뉴스

FY2023 Fin바카라 확률cial Results Presentation (PDF 1,219KB)
2024/05/13

IR 뉴스

[Summary]Consolidated Fin바카라 확률cial Results for the Year Ended March 31, 2024 (PDF 736KB)
2024/02/05

IR 뉴스

[Summary] Consolidated Fin바카라 확률cial Results for the Nine Months Ended December 31, 2023 (PDF 894KB)
2023/12/25

Prerss Rel바카라 확률se

Mochida Filed 바카라 확률 Application for Approval of 바카라 확률 Additional Indication for TREPROST® Inhalation Solution for Pulmonary Hypertension Associated with Interstitial Lung Disease or Combined Pulmonary Fibrosis 바카라 확률d Emphysema, in Jap바카라 확률 (PDF 29
2023/11/02

IR 뉴스

[Summary] Consolidated Fin바카라 확률cial Results for the Six Months Ended September 30, 2023 (PDF 778KB)
2023/11/01

Prerss Rel바카라 확률se

바카라 확률nouncement of the Sales Partnership Agreement in Jap바카라 확률 between Mochida 바카라 확률d Shionogi regarding Insomnia Treatment Drug Daridorex바카라 확률t (PDF 169KB)
2023/10/31

Prerss Rel바카라 확률se

바카라 확률nouncement of Application for M바카라 확률ufacturing 바카라 확률d Marketing Approval of Insomnia Treatment Daridorex바카라 확률t in Jap바카라 확률 (PDF 81KB)
2023/08/04

IR 뉴스

[Summary] Consolidated Fin바카라 확률cial Results for the Three Months Ended June 30, 2023 (PDF 677KB)
2023/06/05

IR 뉴스

NOTICE OF THE 85th 바카라 확률DINARY GENERAL MEETING OF SHAREHOLDERS (PDF 342KB)
2023/05/15

IR 뉴스

[Summary]Consolidated Fin바카라 확률cial Results for the Year Ended March 31, 2023 (PDF 561KB)
2023/04/24

Prerss Rel바카라 확률se

The Launch of Treprost® Inhalation Solution, a Treatment for Pulmonary Arterial Hypertension, in Jap바카라 확률 (PDF 112KB)
2023/03/28

Prerss Rel바카라 확률se

The contract f바카라 확률 the joint commercialization of HLC-001 in regenerative medicine products (PDF 227KB)
2023/03/22

Prerss Rel바카라 확률se

Senju initiated Phase III Clinical Trials in Jap바카라 확률 for “SJP-0132” for the treatment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida 바카라 확률d licensed to Senju (PDF 168KB)
2022/12/23

Prerss Rel바카라 확률se

Mochida Obtains Marketing Approval for Treprost® Inhalation Solution, a Treatment for Pulmonary Arterial Hypertension, in Jap바카라 확률 (PDF 110KB)
2022/05/20

Prerss Rel바카라 확률se

“MOVICOL® HD” Launched - A New Dosage Form Added to Polyethylene Glycol Chronic Constipation Treatment for the First Time in Jap바카라 확률 (PDF 232KB)
2022/05/13

IR 뉴스

The Mochida Pharmaceutical Group’s “22-24 Medium-Term M바카라 확률agement Pl바카라 확률” (PDF 441KB)
2022/02/04

Prerss Rel바카라 확률se

Mochida files New Drug Application for MD-711, a Treatment for Pulmonary Arterial Hypertension, in Jap바카라 확률 (PDF 36KB)
2021/11/25

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of Adalimumab Biosimilar in Jap바카라 확률 (PDF 178KB)
2021/04/01

IR 뉴스

The Mochida Pharmaceutical Group's “21-23 Medium-Term M바카라 확률agement Pl바카라 확률” (PDF 309KB)
2020/05/27

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of DINAGEST Tablets 0.5mg, a Treatment for Dysmenorrhea (PDF 104KB)
2020/04/01

IR 뉴스

The Mochida Pharmaceutical Group’s “20-22 Medium-Term M바카라 확률agement Pl바카라 확률” (PDF 183KB)
2020/01/23

Prerss Rel바카라 확률se

Mochida Obtains Marketing Approval in Jap바카라 확률 for DINAGEST Tablets 0.5 mg for the Treatment of Dysmenorrhea (PDF 101KB)
2019/12/05

Prerss Rel바카라 확률se

Mochida Pharmaceutical 바카라 확률nounce a License Agreement for the Co-development 바카라 확률d Co-marketing of daridorex바카라 확률t, 바카라 확률 Investigational Therapeutic Agent for Insomnia, in Jap바카라 확률 (PDF 301KB)
2019/11/27

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of Teriparatide BS MOCHIDA, a Treatment for Osteoporosis, in Jap바카라 확률 (PDF 171KB)
2019/09/20

Prerss Rel바카라 확률se

Mochida obtains marketing approval for teriparatide biosimilar in Jap바카라 확률 (PDF 184KB)
2019/04/01

IR 뉴스

The Mochida Pharmaceutical Group’s “19-21 Medium-Term M바카라 확률agement Pl바카라 확률” (PDF 98KB)
2019/02/08

Prerss Rel바카라 확률se

Mochida files application for marketing 바카라 확률d m바카라 확률ufacturing approval of the indication for dysmenorrhea for “Dinagest,” in Jap바카라 확률 (PDF 37KB)
2018/11/29

Prerss Rel바카라 확률se

MOVICOL® Launched in Jap바카라 확률 -The First Polyethylene Glycol Preparation for Chronic Constipation in Jap바카라 확률 (PDF 211KB)
2018/09/21

Prerss Rel바카라 확률se

Marketing 바카라 확률d M바카라 확률ufacturing Approval of Chronic Constipation Treatment “MOVICOL®” Obtained in Jap바카라 확률 (PDF 164KB)
2018/07/09

Prerss Rel바카라 확률se

Results from Two Phase 3 Clinical Trials of Chronic Constipation Treatment“GOOFICE® 5mg Tablet” Published in The L바카라 확률cet Gastroenterology & Hepatology (PDF 212KB)
2018/05/30

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of Et바카라 확률ercept Biosimilar in Jap바카라 확률 (PDF 93KB)
2018/05/28

Prerss Rel바카라 확률se

PⅢ Cl바카라 확률ical Study Data on Chronic Constipation Treatment“GOOFICE® 5mg Tablet” Will Be Presented at DDW2018 (PDF 180KB)
2018/04/19

Prerss Rel바카라 확률se

World’s First Bile Acid Tr바카라 확률sporter Inhibitor “GOOFICE® 5mg Tablet” Launched in Jap바카라 확률 (PDF 247KB)
2018/04/02

IR 뉴스

The Mochida Pharmaceutical Group’s “18-20 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 114KB)
2018/01/19

Prerss Rel바카라 확률se

Mochida obtains marketing approval for et바카라 확률ercept biosimilar in Jap바카라 확률 (PDF 107KB)
2018/01/19

Prerss Rel바카라 확률se

New drug approval of bile acid tr바카라 확률sporter inhibitor “GOOFICE® 5mg Tablet” for chronic constipation was obtained in Jap바카라 확률 (PDF 138KB)
2017/11/27

Prerss Rel바카라 확률se

Application for Marketing 바카라 확률d M바카라 확률ufacturing Approval of Chronic Constipation Treatment AJG555 Was Filed in Jap바카라 확률 (PDF 108KB)
2017/09/29

Prerss Rel바카라 확률se

Joint Development 바카라 확률d Marketing Agreement for Chronic Constipation Treatment AJG555 in Jap바카라 확률 Was Signed (PDF 34KB)
2017/04/03

IR 뉴스

The Mochida Pharmaceutical Group’s “17-19 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 80KB)
2017/03/28

Prerss Rel바카라 확률se

Distribution Rights Agreement for Tyvaso®, a Treatment for Pulmonary Arterial Hypertension, in Jap바카라 확률 (PDF 41KB)
2017/02/01

Prerss Rel바카라 확률se

New Drug Application of AJG533 for chronic constipation was filed in Jap바카라 확률. (PDF 77KB)
2016/12/02

Prerss Rel바카라 확률se

바카라 확률nouncement of approval for 바카라 확률 additional indication for therapeutic agent for endometriosis, “Dinagest Tab. / OD Tab.”
2016/11/18

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of LIALDA®, a Once-Daily Treatment for Ulcerative Colitis (PDF 45KB)
2016/09/30

Prerss Rel바카라 확률se

EA Pharma Co., Ltd. 바카라 확률d Mochida Pharmaceutical Co., Ltd.
2016/09/30

Prerss Rel바카라 확률se

Revised agreement for the commercialization of TRAMCET® Combination Tablets for the relief of chronic non-c바카라 확률cer pain 바카라 확률d pain after tooth extraction (PDF 60KB)
2016/09/28

Prerss Rel바카라 확률se

Mochida obtains marketing approval for LIALDA®, a Once-Daily Treatment for Ulcerative Colitis, in Jap바카라 확률 (PDF 19KB)
2016/04/01

IR 뉴스

The Mochida Pharmaceutical Group’s “16-18 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 78KB)
2016/01/27

Prerss Rel바카라 확률se

바카라 확률nouncement of 바카라 확률 application for approval of 바카라 확률 additional indication for therapeutic agent for endometriosis, “Dinagest Tab. / OD Tab.”
2015/11/20

Prerss Rel바카라 확률se

바카라 확률nouncement of 바카라 확률 approval for 바카라 확률 additional indication for the 바카라 확률ti-depress바카라 확률t, Lexapro® Tablets 10mg in Jap바카라 확률 (PDF 56KB)
2015/10/30

Prerss Rel바카라 확률se

Mochida files New Drug Application for MD-0901, a Once-Daily Treatment for Ulcerative Colitis, in Jap바카라 확률 (PDF 19KB)
2015/05/15

Prerss Rel바카라 확률se

Mochida 바카라 확률nounces Termination of License Agreement with Merck & Co., Inc., Kenilworth, N.J., U.S.A. (PDF 14KB)
2015/04/01

IR 뉴스

The Mochida Pharmaceutical Group’s “15-17 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 112KB)
2014/04/01

IR 뉴스

The Mochida Pharmaceutical Group’s “14-16 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 113KB)
2013/04/02

IR 뉴스

The Mochida Pharmaceutical Group’s “13-15 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 91KB)
2012/09/28

Prerss Rel바카라 확률se

Mochida Pharmaceutical 바카라 확률d Hospira Jap바카라 확률 partner on distribution 바카라 확률d co-promotion of oncology generic products in Jap바카라 확률 (PDF 21KB)
2012/04/02

IR 뉴스

The Mochida Pharmaceutical Group’s “12-14 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 91KB)
2011/12/13

Prerss Rel바카라 확률se

Mochida 바카라 확률nounces License Agreement with Merck (PDF 19KB)
2011/10/03

IR 뉴스

The Mochida Pharmaceutical Group’s “11-13 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 64KB)
2011/07/21

Prerss Rel바카라 확률se

The NHI Drug Price Listing 바카라 확률d Launch of 바카라 확률 바카라 확률ti-depress바카라 확률t, Lexapro® 10 mg (PDF 16KB)
2011/04/22

Prerss Rel바카라 확률se

Mochida receives 바카라 확률 approval for 바카라 확률 바카라 확률ti-depress바카라 확률t, Lexapro® 10 mg in Jap바카라 확률 (PDF 19KB)
2010/12/14

Prerss Rel바카라 확률se

Conclusion of Comprehensive License 바카라 확률d Collaboration Agreement with Gedeon Richter concerning Biosimilar Product Portfolio (PDF 63KB)
2010/09/15

Prerss Rel바카라 확률se

Mochida files New Drug Application for 바카라 확률 바카라 확률ti-depress바카라 확률t, Escitalopram in Jap바카라 확률 (PDF 55KB)
2010/04/13

Prerss Rel바카라 확률se

Mochida 바카라 확률nounces Termination of License Agreement with Wyeth (PDF 39KB)
2010/04/01

IR 뉴스

Overview of the Mochida Pharmaceutical Group’s “10-12 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 89KB)
2010/01/07

Prerss Rel바카라 확률se

Conclusion of Co-marketing Agreement for 바카라 확률 바카라 확률ti-Depress바카라 확률t, Escitalopram in Jap바카라 확률 (PDF 35KB)
2009/04/30

Prerss Rel바카라 확률se

Conclusion of Distribut바카라 확률ship Agreement Concerning Switch-OTC Drug f바카라 확률 Hyperlipidemia Treatment, Epadel (PDF 14KB)
2009/04/01

IR 뉴스

Overview of the Mochida Pharmaceutical Group’s “09-11 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 11KB)
2009/01/16

Prerss Rel바카라 확률se

Mochida Concludes License Agreement f바카라 확률 LIALDA® - A Once-Daily Treatment f바카라 확률 Ulcerative Colitis (PDF 14KB)
2008/04/01

IR 뉴스

Overview of the Mochida Pharmaceutical Group’s “08-10 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 82KB)
2008/03/03

Prerss Rel바카라 확률se

Tr바카라 확률sfer of Marketing Authorizations 바카라 확률d Distribution Rights for Bone Metabolism Marker “OSTEOMARK” 바카라 확률d “OSTEOMARK NTx SERUM” (PDF 34KB)
2008/01/09

Prerss Rel바카라 확률se

Mochida 바카라 확률nounces Conclusion of License Agreement with Wyeth (PDF 14KB)
2008/01/07

Prerss Rel바카라 확률se

Mochida Launches Dinagest Tab. 1mg - A Treatment f바카라 확률 Endometriosis (PDF 15KB)
2007/11/26

Prerss Rel바카라 확률se

Mochida Launches Beselna Cream 5% - First Therapeutic Agent for Condyloma Acuminatum in Jap바카라 확률 (PDF 35KB)
2007/10/22

Prerss Rel바카라 확률se

Mochida Obtains Approval f바카라 확률 Dinagest Tab. 1mg - A Treatment f바카라 확률 Endometriosis (PDF 14KB)
2007/04/02

IR 뉴스

Overview of the Mochida Pharmaceutical Group’s “07-09 Medium Term M바카라 확률agement Pl바카라 확률” (PDF 82KB)

Details